心房颤动急性缺血性卒中的抗凝剂:叙述性综述

S. J. B. Sayeed, Md Moniruzzaman, Md Mujibur Rahman
{"title":"心房颤动急性缺血性卒中的抗凝剂:叙述性综述","authors":"S. J. B. Sayeed, Md Moniruzzaman, Md Mujibur Rahman","doi":"10.3329/jom.v25i2.74657","DOIUrl":null,"url":null,"abstract":"Embolic stroke due to atrial fibrillation is often underdiagnosed and has high morbidity and mortality among ischemic stroke. So it is of paramount importance to start anticoagulants as early as possible to prevent further ischemic stroke. However, early initiation of anticoagulants has created much debate, major & minor bleeding related to it are a major concern, and resumption of anticoagulants after intracranial hemorrhage is still a gray zone. Here, we described a narrative review to shed some light on the major concerns such as the optimal time to start an anticoagulant, the best agent to administer, the resumption of anticoagulant after a hemorrhagic stroke, and anticoagulant therapy in chronic rheumatic heart disease (CRHD) based on the recently published article.\nJ MEDICINE 2024; 25: 155-158","PeriodicalId":76013,"journal":{"name":"Journal of medicine","volume":"9 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anticoagulant in Acute Ischemic Stroke with Atrial Fibrillation: A Narrative Review\",\"authors\":\"S. J. B. Sayeed, Md Moniruzzaman, Md Mujibur Rahman\",\"doi\":\"10.3329/jom.v25i2.74657\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Embolic stroke due to atrial fibrillation is often underdiagnosed and has high morbidity and mortality among ischemic stroke. So it is of paramount importance to start anticoagulants as early as possible to prevent further ischemic stroke. However, early initiation of anticoagulants has created much debate, major & minor bleeding related to it are a major concern, and resumption of anticoagulants after intracranial hemorrhage is still a gray zone. Here, we described a narrative review to shed some light on the major concerns such as the optimal time to start an anticoagulant, the best agent to administer, the resumption of anticoagulant after a hemorrhagic stroke, and anticoagulant therapy in chronic rheumatic heart disease (CRHD) based on the recently published article.\\nJ MEDICINE 2024; 25: 155-158\",\"PeriodicalId\":76013,\"journal\":{\"name\":\"Journal of medicine\",\"volume\":\"9 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3329/jom.v25i2.74657\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/jom.v25i2.74657","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

心房颤动导致的栓塞性中风往往诊断不足,在缺血性中风中具有较高的发病率和死亡率。因此,尽早开始使用抗凝药物以预防进一步的缺血性中风至关重要。然而,早期开始使用抗凝药物引起了许多争论,与此相关的大出血和小出血是一个主要问题,而颅内出血后恢复使用抗凝药物仍是一个灰色地带。在此,我们以最近发表的一篇文章为基础,对开始使用抗凝剂的最佳时间、最佳用药、出血性卒中后抗凝剂的恢复以及慢性风湿性心脏病(CRHD)的抗凝治疗等主要问题进行了叙述性综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Anticoagulant in Acute Ischemic Stroke with Atrial Fibrillation: A Narrative Review
Embolic stroke due to atrial fibrillation is often underdiagnosed and has high morbidity and mortality among ischemic stroke. So it is of paramount importance to start anticoagulants as early as possible to prevent further ischemic stroke. However, early initiation of anticoagulants has created much debate, major & minor bleeding related to it are a major concern, and resumption of anticoagulants after intracranial hemorrhage is still a gray zone. Here, we described a narrative review to shed some light on the major concerns such as the optimal time to start an anticoagulant, the best agent to administer, the resumption of anticoagulant after a hemorrhagic stroke, and anticoagulant therapy in chronic rheumatic heart disease (CRHD) based on the recently published article. J MEDICINE 2024; 25: 155-158
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信